8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Feb 2, 2026·SEC
Material company update
Nov 25, 2025·SEC
DaVita Inc.(DVA)Earnings, Financials & Key Ratios
DVA•NYSE
21.9× P/E·Price updated Jun 19, 2026
AboutDaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Show more
- Revenue$13.64B+6.5%
- EBITDA$2.73B-3.1%
- Net Income$747M-20.2%
- EPS (Diluted)9.51-11.4%
- Gross Margin27%-17.9%
- EBITDA Margin19.98%-9.0%
- Operating Margin14.74%-9.7%
- Net Margin5.47%-25.1%
- ROE45.96%+18.7%
DVA Key Insights
DaVita Inc. (DVA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 37.5%
- ✓Momentum leader: RS Rating 91 (top 9%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Trading near 52-week high
✗Weaknesses
- ✗High debt to equity ratio of 13.0x
- ✗Expensive at 15.8x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when DVA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DVA Price & Volume
DaVita Inc. (DVA) stock price & volume — 10-year historical chart
Loading chart...
DVA Growth Metrics
DaVita Inc. (DVA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-0.1%
5 Years3.39%
3 Years5.53%
TTM6.68%
Profit CAGR
10 Years10.72%
5 Years-0.7%
3 Years10.04%
TTM-9.1%
EPS CAGR
10 Years22.5%
5 Years8.28%
3 Years18.54%
TTM-1.49%
Return on Capital
10 Years11.83%
5 Years12.28%
3 Years13.3%
Last Year14.04%
DVA Recent Earnings
DaVita Inc. (DVA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$2.87+19.1%
$2.41
Rev
$3.4B+1.8%
$3.4B
Q1 2026
Feb 2, 2026Metric
Actual
Est
EPS
$3.40+4.9%
$3.24
Rev
$3.6B+3.2%
$3.5B
Q4 2025
Oct 29, 2025Metric
Actual
Est
EPS
$2.51-20.8%
$3.17
Rev
$3.4B-0.2%
$3.4B
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$2.95+9.3%
$2.70
Rev
$3.4B-1.8%
$3.4B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $2.87vs $2.41+19.1% | $3.4Bvs $3.4B+1.8% |
| Q1 2026 | Feb 2, 2026 | $3.40vs $3.24+4.9% | $3.6Bvs $3.5B+3.2% |
| Q4 2025 | Oct 29, 2025 | $2.51vs $3.17-20.8% | $3.4Bvs $3.4B-0.2% |
| Q3 2025 | Aug 5, 2025 | $2.95vs $2.70+9.3% | $3.4Bvs $3.4B-1.8% |
Based on last 12 quarters of dataView full earnings history →
DVA Peer Comparison
DaVita Inc. (DVA) competitors in Specialty chronic care clinics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 FMS | 12.99B | 23.59 | 12.20 | 1.51% | 4.89% | 6.68% | 0.76 | |
 FXNC | 265.44M | 29.36 | 14.98 | 27.11% | 15.35% | 9.98% | 0.23 | |
 UNH | 363.94B | 400.96 | 30.31 | 11.81% | 2.68% | 11.54% | 0.77 | |
 HUM | 43.3B | 360.65 | 36.65 | 10.06% | 0.82% | 6.17% | 0.73 | |
 CNC | 30.13B | 61.02 | -4.48 | 19.44% | -3.25% | -28.6% | 0.94 | |
 USPH | 964.39M | 63.32 | 44.59 | 16.33% | 1.52% | 1.36% | 0.55 | |
 AMSF | 588.66M | 31.32 | 12.68 | 2.63% | 14.27% | 9.68% | 0.00 | |
 PNTG | 1.16B | 33.44 | 39.81 | 36.31% | 2.96% | 8.42% | 1.21 |
Compare DVA vs Peers
DaVita Inc. (DVA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DVA Income Statement
DaVita Inc. (DVA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 10.88B | 11.4B | 11.39B | 11.55B | 11.62B | 11.61B | 12.14B | 12.82B | 13.64B | 13.84B |
Revenue Growth % | -26.24% | 4.86% | -0.14% | 1.42% | 0.59% | -0.08% | 4.57% | 5.56% | 6.46% | 6.68% |
Cost of Goods Sold | 7.64B | 8.2B | 7.91B | 7.99B | 7.97B | 8.21B | 8.32B | 8.6B | 9.96B | 9.53B |
COGS % of Revenue | 70.24% | 71.86% | 69.5% | 69.16% | 68.62% | 70.71% | 68.53% | 67.09% | 73% | - |
Gross Profit | 3.24B▲ 0% | 3.21B▼ 0.8% | 3.47B▲ 8.2% | 3.56B▲ 2.5% | 3.65B▲ 2.4% | 3.4B▼ 6.7% | 3.82B▲ 12.4% | 4.22B▲ 10.4% | 3.68B▼ 12.6% | 4.3B▲ 0% |
Gross Margin % | 29.76% | 28.14% | 30.5% | 30.84% | 31.38% | 29.29% | 31.47% | 32.91% | 27% | 31.1% |
Gross Profit Growth % | -1.2% | -0.84% | 8.25% | 2.53% | 2.37% | -6.75% | 12.35% | 10.38% | -12.63% | - |
Operating Expenses | 1.42B | 1.68B | 1.83B | 1.87B | 1.85B | 2.06B | 2.22B | 2.13B | 1.67B | 2.23B |
OpEx % of Revenue | 13.09% | 14.76% | 16.07% | 16.17% | 15.91% | 17.75% | 18.27% | 16.59% | 12.27% | - |
Selling, General & Admin | 1.06B | 1.14B | 1.1B | 1.25B | 1.2B | 1.36B | 1.47B | 1.54B | 1.67B | 1.72B |
SG&A % of Revenue | 9.78% | 9.96% | 9.69% | 10.8% | 10.29% | 11.67% | 12.14% | 12% | 12.27% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 359.85M | 548.06M | 727.37M | 619.77M | 653.68M | 706.08M | 743.66M | 588.21M | 0 | 3M |
Operating Income | 1.81B▲ 0% | 1.53B▼ 15.8% | 1.64B▲ 7.7% | 1.69B▲ 3.1% | 1.8B▲ 6.1% | 1.34B▼ 25.5% | 1.6B▲ 19.7% | 2.09B▲ 30.4% | 2.01B▼ 3.8% | 2.08B▲ 0% |
Operating Margin % | 16.67% | 13.38% | 14.43% | 14.67% | 15.47% | 11.53% | 13.2% | 16.31% | 14.74% | 15.01% |
Operating Income Growth % | -10.69% | -15.83% | 7.7% | 3.12% | 6.06% | -25.5% | 19.69% | 30.43% | -3.82% | - |
EBITDA | 2.37B | 2.12B | 2.26B | 2.33B | 2.48B | 2.07B | 2.35B | 2.81B | 2.73B | 2.79B |
EBITDA Margin % | 21.81% | 18.56% | 19.83% | 20.13% | 21.33% | 17.84% | 19.34% | 21.96% | 19.98% | 20.19% |
EBITDA Growth % | -6.56% | -10.78% | 6.69% | 2.95% | 6.58% | -16.4% | 13.35% | 19.85% | -3.14% | 1.26% |
D&A (Non-Cash Add-back) | 559.91M | 591.03M | 615.15M | 630.43M | 680.62M | 732.6M | 745.44M | 723.86M | 715.35M | 716.73M |
EBIT | 1.83B | 1.54B | 1.64B | 1.62B | 1.8B | 1.32B | 1.58B | 2B | 1.93B | 1.98B |
Net Interest Income | -430.63M | -487.44M | -443.82M | -304.11M | -285.25M | -357.02M | -398.55M | -470.47M | -549.67M | -559.75M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 430.63M | 487.44M | 443.82M | 304.11M | 285.25M | 357.02M | 398.55M | 470.47M | 549.67M | 559.75M |
Other Income/Expense | -412.97M | -477.35M | -447.88M | -376.37M | -278.88M | -372.78M | -425.69M | -560.09M | -663.79M | -674.98M |
Pretax Income | 1.4B▲ 0% | 1.05B▼ 25.1% | 1.2B▲ 14.0% | 1.32B▲ 10.3% | 1.52B▲ 15.2% | 966.28M▼ 36.4% | 1.18B▲ 21.8% | 1.53B▲ 30.0% | 1.35B▼ 12.0% | 1.4B▲ 0% |
Pretax Margin % | 12.87% | 9.19% | 10.5% | 11.41% | 13.07% | 8.32% | 9.7% | 11.94% | 9.87% | 10.13% |
Income Tax | 323.86M | 258.4M | 279.63M | 313.93M | 306.73M | 198.09M | 220.12M | 279.66M | 293.11M | 305.19M |
Effective Tax Rate % | 23.14% | 24.65% | 23.39% | 23.81% | 20.2% | 20.5% | 18.7% | 18.27% | 21.76% | 21.77% |
Net Income | 663.62M▲ 0% | 159.39M▼ 76.0% | 810.98M▲ 408.8% | 773.64M▼ 4.6% | 978.45M▲ 26.5% | 560.4M▼ 42.7% | 691.53M▲ 23.4% | 936.34M▲ 35.4% | 746.8M▼ 20.2% | 781.42M▲ 0% |
Net Margin % | 6.1% | 1.4% | 7.12% | 6.7% | 8.42% | 4.83% | 5.7% | 7.31% | 5.47% | 5.65% |
Net Income Growth % | -24.58% | -75.98% | 408.79% | -4.6% | 26.47% | -42.73% | 23.4% | 35.4% | -20.24% | -9.1% |
Net Income (Continuing) | 1.08B | 790.08M | 915.81M | 1B | 1.21B | 768.19M | 956.98M | 1.25B | 1.05B | 1.1B |
Discontinued Operations | -245.37M | -457.04M | 105.48M | -9.65M | 0 | 13.45M | 0 | 0 | 25M | 1000K |
Minority Interest | 1.21B | 1.33B | 1.37B | 1.51B | 1.62B | 1.51B | 1.69B | 1.97B | 1.81B | 1.8B |
EPS (Diluted) | 3.47▲ 0% | 4.58▲ 32.0% | 5.27▲ 15.1% | 6.39▲ 21.3% | 8.90▲ 39.3% | 5.71▼ 35.8% | 7.42▲ 29.9% | 10.73▲ 44.6% | 9.51▼ 11.4% | 11.35▲ 0% |
EPS Growth % | -19.11% | 31.99% | 15.07% | 21.25% | 39.28% | -35.84% | 29.95% | 44.61% | -11.37% | -1.49% |
EPS (Basic) | 3.52 | 4.63 | 5.29 | 6.54 | 9.30 | 5.88 | 7.62 | 11.02 | 9.72 | - |
Diluted Shares Outstanding | 191.35M | 172.36M | 153.81M | 122.62M | 109.95M | 95.83M | 93.18M | 87.27M | 88.1M | 68.88M |
Basic Shares Outstanding | 188.63M | 170.79M | 153.18M | 119.8M | 105.23M | 92.99M | 90.79M | 84.99M | 86.1M | 67.39M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
DVA Balance Sheet
DaVita Inc. (DVA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 8.74B | 8.42B | 3.69B | 3.15B | 3.17B | 3.16B | 3.14B | 3.75B | 4.06B | 4.06B |
Cash & Short-Term Investments | 541.06M | 325.97M | 1.11B | 345.06M | 484.21M | 321.78M | 391.67M | 846M | 782.05M | 748.71M |
Cash Only | 508.23M | 323.04M | 1.1B | 324.96M | 461.9M | 244.09M | 380.06M | 794.93M | 757.75M | 726.4M |
Short-Term Investments | 43.52M | 2.94M | 11.57M | 20.1M | 22.31M | 77.69M | 11.61M | 51.06M | 24.3M | 22.3M |
Accounts Receivable | 2.16B | 2.4B | 2.31B | 2.44B | 2.41B | 2.55B | 2.42B | 2.56B | 2.96B | 2.98B |
Days Sales Outstanding | 72.6 | 76.71 | 73.88 | 77.07 | 75.73 | 80.19 | 72.64 | 72.85 | 79.16 | 78.65 |
Inventory | 181.8M | 107.38M | 97.95M | 111.63M | 107.43M | 109.12M | 143.1M | 134.56M | 160.63M | 141.61M |
Days Inventory Outstanding | 8.69 | 4.78 | 4.52 | 5.1 | 4.92 | 4.85 | 6.28 | 5.71 | 5.89 | 5.62 |
Other Current Assets | 5.78B | 5.48B | 106.35M | 176.83M | 93.06M | 173.74M | 187.22M | 207.84M | 156.28M | 35.78M |
Total Non-Current Assets | 10.2B | 10.69B | 13.62B | 13.84B | 13.95B | 13.77B | 13.76B | 13.54B | 13.42B | 13.44B |
Property, Plant & Equipment | 3.15B | 3.39B | 6.3B | 6.38B | 6.3B | 5.92B | 5.57B | 5.33B | 5.21B | 5.15B |
Fixed Asset Turnover | 3.45x | 3.36x | 1.81x | 1.81x | 1.84x | 1.96x | 2.18x | 2.40x | 2.62x | 2.61x |
Goodwill | 6.61B | 6.84B | 6.79B | 6.92B | 7.05B | 7.08B | 7.11B | 7.38B | 7.55B | 7.58B |
Intangible Assets | 113.83M | 118.85M | 135.68M | 166.59M | 177.69M | 182.69M | 203.22M | 197.43M | 222.13M | 229.02M |
Long-Term Investments | 283.23M | 260.04M | 278.5M | 289.68M | 288.39M | 275.44M | 593.74M | 370.34M | 198.22M | 838.98M |
Other Non-Current Assets | 47.29M | 71.58M | 115.97M | 79.5M | 136.68M | 315.59M | 271.25M | 261.73M | 246.52M | 434.43M |
Total Assets | 18.95B▲ 0% | 19.11B▲ 0.9% | 17.31B▼ 9.4% | 16.99B▼ 1.9% | 17.12B▲ 0.8% | 16.93B▼ 1.1% | 16.89B▼ 0.2% | 17.29B▲ 2.3% | 17.48B▲ 1.1% | 17.5B▲ 0% |
Asset Turnover | 0.57x | 0.60x | 0.66x | 0.68x | 0.68x | 0.69x | 0.72x | 0.74x | 0.78x | 0.79x |
Asset Growth % | 1.1% | 0.86% | -9.41% | -1.87% | 0.78% | -1.13% | -0.2% | 2.32% | 1.13% | 7.46% |
Total Current Liabilities | 3.04B | 4.89B | 2.37B | 2.48B | 2.4B | 2.62B | 2.64B | 2.97B | 3.14B | 2.87B |
Accounts Payable | 509.12M | 463.27M | 403.84M | 434.25M | 402.05M | 479.78M | 514.53M | 547.2M | 696.15M | 691.26M |
Days Payables Outstanding | 24.32 | 20.63 | 18.62 | 19.84 | 18.41 | 21.33 | 22.57 | 23.23 | 25.51 | 25.25 |
Short-Term Debt | 178.21M | 1.93B | 130.71M | 168.54M | 179.03M | 231.4M | 123.3M | 270.87M | 109.2M | 112.65M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2.2B | 2.33B | 1.3B | 1.37B | 1.24B | 1.35B | 1.42B | 1.53B | 1.09B | 836.79M |
Current Ratio | 2.88x | 1.72x | 1.56x | 1.27x | 1.32x | 1.20x | 1.19x | 1.26x | 1.29x | 1.42x |
Quick Ratio | 2.82x | 1.70x | 1.51x | 1.23x | 1.28x | 1.16x | 1.13x | 1.21x | 1.24x | 1.37x |
Cash Conversion Cycle | 56.96 | 60.86 | 59.77 | 62.33 | 62.24 | 63.71 | 56.34 | 55.33 | 59.54 | 59.03 |
Total Non-Current Liabilities | 10.01B | 9.19B | 11.44B | 11.62B | 12.35B | 12.08B | 11.51B | 12.22B | 13.18B | 13.58B |
Long-Term Debt | 9.16B | 8.17B | 7.98B | 7.92B | 8.73B | 8.69B | 8.27B | 9.18B | 12.34B | 10.51B |
Capital Lease Obligations | 0 | 0 | 2.72B | 2.74B | 2.67B | 2.5B | 2.33B | 2.21B | 2.18B | 8.56B |
Deferred Tax Liabilities | 486.25M | 562.54M | 577.54M | 809.6M | 830.95M | 782.79M | 726.22M | 665.36M | 756.87M | 2.96B |
Other Non-Current Liabilities | 365.32M | 450.67M | 160.81M | 150.06M | 119.16M | 105.23M | 183.07M | 169.59M | -2.09B | 88.85M |
Total Liabilities | 13.08B | 14.08B | 13.81B | 14.09B | 14.75B | 14.7B | 14.15B | 15.19B | 16.32B | 16.45B |
Total Debt | 9.34B | 10.1B | 11.18B | 11.19B | 11.98B | 11.82B | 11.12B | 12.07B | 15.05B | 13.22B |
Net Debt | 8.83B | 9.78B | 10.07B | 10.87B | 11.51B | 11.58B | 10.74B | 11.27B | 14.29B | 12.49B |
Debt / Equity | 1.58x | 2.01x | 3.19x | 3.86x | 5.05x | 5.31x | 4.05x | 5.77x | 12.99x | 12.61x |
Debt / EBITDA | 3.93x | 4.77x | 4.95x | 4.81x | 4.83x | 5.71x | 4.73x | 4.29x | 5.52x | 4.73x |
Net Debt / EBITDA | 3.72x | 4.62x | 4.46x | 4.67x | 4.65x | 5.59x | 4.57x | 4.01x | 5.24x | 4.47x |
Interest Coverage | 4.25x | 3.15x | 3.69x | 5.33x | 6.32x | 3.71x | 3.95x | 4.25x | 3.51x | 3.54x |
Total Equity | 5.9B▲ 0% | 5.03B▼ 14.7% | 3.5B▼ 30.5% | 2.9B▼ 17.2% | 2.37B▼ 18.2% | 2.22B▼ 6.2% | 2.74B▲ 23.3% | 2.09B▼ 23.8% | 1.16B▼ 44.6% | 1.05B▲ 0% |
Equity Growth % | 1.28% | -14.66% | -30.47% | -17.23% | -18.15% | -6.17% | 23.31% | -23.77% | -44.61% | -148.57% |
Book Value per Share | 30.82 | 29.20 | 22.75 | 23.62 | 21.56 | 23.22 | 29.44 | 23.96 | 13.15 | 15.22 |
Total Shareholders' Equity | 4.69B | 3.7B | 2.13B | 1.38B | 755.51M | 712.33M | 1.06B | 121.12M | -651.08M | -755.5M |
Common Stock | 182K | 166K | 126K | 110K | 97K | 90K | 89K | 90K | 69K | 69K |
Retained Earnings | 3.63B | 2.74B | 1.43B | 852.54M | 354.34M | 174.49M | 598.29M | 1.53B | -328.43M | -179.24M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.39B | -199.94M | -489.36M |
Accumulated OCI | 13.23M | -34.92M | -47.5M | -66.15M | -139.25M | -69.19M | -52.08M | -310.8M | -122.78M | -86.96M |
Minority Interest | 1.21B | 1.33B | 1.37B | 1.51B | 1.62B | 1.51B | 1.69B | 1.97B | 1.81B | 1.8B |
DVA Cash Flow Statement
DaVita Inc. (DVA) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.91B | 1.77B | 2.07B | 1.98B | 1.93B | 1.56B | 2.06B | 2.02B | 1.89B | 2.03B |
Operating CF Margin % | 17.54% | 15.53% | 18.2% | 17.13% | 16.62% | 13.48% | 16.96% | 15.78% | 13.83% | - |
Operating CF Growth % | -2.85% | -7.12% | 16.97% | -4.5% | -2.43% | -18.97% | 31.6% | -1.8% | -6.7% | 21.4% |
Net Income | 830.55M | 333.04M | 1.02B | 994.68M | 1.21B | 781.64M | 691.53M | 1.25B | 1.08B | 781.42M |
Depreciation & Amortization | 777.49M | 591.03M | 615.15M | 630.43M | 680.62M | 732.6M | 745.44M | 723.86M | 715.35M | 530.19M |
Stock-Based Compensation | 35.09M | 73.06M | 67.85M | 91.46M | 102.21M | 95.43M | 112.38M | 102.79M | 139.95M | 99.96M |
Deferred Taxes | -395.22M | 273.66M | 41.72M | 240.85M | 60.48M | -75.67M | -39.35M | -57.84M | 86.57M | 119.45M |
Other Non-Cash Items | 1.05B | 401.94M | 239.48M | 125.78M | 16.45M | 30.47M | 354.5M | 32.31M | 129.15M | 612.68M |
Working Capital Changes | -394.5M | 98.9M | 86.86M | -104.17M | -140.64M | 101K | 194.53M | -29.82M | -263.24M | -194.76M |
Change in Receivables | -156.31M | -81.18M | -79.96M | -21.09M | -138.14M | -148.39M | 172.36M | -29.77M | -210.63M | -85.11M |
Change in Inventory | -18.63M | 73.5M | 10.16M | -12.35M | 5.72M | -757K | -32.13M | 17.94M | -19.95M | 15.1M |
Change in Payables | 26.88M | -35.96M | -84.54M | 37.2M | -30.32M | 87.48M | 26.89M | 1.7M | 128.3M | 58.33M |
Cash from Investing | -1.37B | -1.01B | 3B | -825.37M | -784.73M | -630.35M | -771.8M | -771.43M | -654.95M | -631.9M |
Capital Expenditures | -905.25M | -987.14M | -766.55M | -674.54M | -641.47M | -603.43M | -567.99M | -555.44M | -575.86M | -534.62M |
CapEx % of Revenue | 8.32% | 8.66% | 6.73% | 5.84% | 5.52% | 5.2% | 4.68% | 4.33% | 4.22% | 3.86% |
Acquisitions | -808.7M | -202.33M | -110.23M | -204.35M | -200.97M | -89.19M | -26.39M | -251.27M | 0 | -34.13M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 92.44M | 153.85M | 3.88B | 53.28M | 63.66M | 120.76M | 35.52M | 32.54M | -36.34M | -48.32M |
Cash from Financing | -766.26M | -625.35M | -4.7B | -1.85B | -1.08B | -1.12B | -1.17B | -816.94M | -1.37B | -1.21B |
Debt Issued (Net) | 154.85M | 699.8M | -2.08B | -169.38M | 754.25M | -11.28M | -552.62M | 1.11B | 769.62M | 1.65B |
Equity Issued (Net) | -802.95M | -1.15B | -2.37B | -1.46B | -1.6B | -783.65M | -255.32M | -1.37B | -1.77B | -1.62B |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -802.95M | -1.16B | -2.38B | -1.46B | -1.6B | -802.23M | -272.22M | -1.39B | -1.79B | -1.65B |
Other Financing | -118.16M | -177.22M | -243.82M | -217.98M | -238.59M | -326.2M | -362.56M | -560.55M | -374.69M | -1.24B |
Net Change in Cash | -166.54M▲ 0% | -103.5M▲ 37.9% | 793.3M▲ 866.5% | -706.93M▼ 189.1% | 53.17M▲ 107.5% | -215.97M▼ 506.2% | 125.64M▲ 158.2% | 415.19M▲ 230.4% | -122.08M▼ 129.4% | 201.83M▲ 0% |
Free Cash Flow | 1B▲ 0% | 784.5M▼ 21.7% | 1.31B▲ 66.5% | 1.3B▼ 0.1% | 1.29B▼ 1.2% | 961.14M▼ 25.5% | 1.49B▲ 55.1% | 1.47B▼ 1.6% | 1.31B▼ 10.6% | 1.49B▲ 0% |
FCF Margin % | 9.21% | 6.88% | 11.47% | 11.29% | 11.1% | 8.28% | 12.28% | 11.44% | 9.61% | 10.79% |
FCF Growth % | -11.65% | -21.72% | 66.45% | -0.1% | -1.16% | -25.46% | 55.13% | -1.64% | -10.63% | -15.15% |
FCF per Share | 5.24 | 4.55 | 8.49 | 10.64 | 11.73 | 10.03 | 16.00 | 16.80 | 14.88 | 21.67 |
FCF Conversion (FCF/Net Income) | 2.87x | 11.11x | 2.56x | 2.56x | 1.97x | 2.79x | 2.98x | 2.16x | 2.53x | 1.91x |
Interest Paid | 424.55M | 488.97M | 473.18M | 326.17M | 279M | 351M | 387.66M | 423.36M | 0 | 0 |
Taxes Paid | 387.16M | 92.53M | 157.98M | 154.85M | 154.85M | 344.43M | 268.09M | 387.94M | 0 | 0 |
DVA Key Ratios
DaVita Inc. (DVA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 11.32% | 2.92% | 19.01% | 24.19% | 37.15% | 24.39% | 27.84% | 38.73% | 45.96% | 59.11% |
Return on Invested Capital (ROIC) | 9.38% | 7.75% | 8.68% | 9.3% | 9.75% | 7.25% | 8.81% | 11.68% | 10.47% | 10.68% |
Gross Margin | 29.76% | 28.14% | 30.5% | 30.84% | 31.38% | 29.29% | 31.47% | 32.91% | 27% | 31.1% |
Net Margin | 6.1% | 1.4% | 7.12% | 6.7% | 8.42% | 4.83% | 5.7% | 7.31% | 5.47% | 5.65% |
Debt / Equity | 1.58x | 2.01x | 3.19x | 3.86x | 5.05x | 5.31x | 4.05x | 5.77x | 12.99x | 12.61x |
Interest Coverage | 4.25x | 3.15x | 3.69x | 5.33x | 6.32x | 3.71x | 3.95x | 4.25x | 3.51x | 3.54x |
FCF Conversion | 2.87x | 11.11x | 2.56x | 2.56x | 1.97x | 2.79x | 2.98x | 2.16x | 2.53x | 1.91x |
Revenue Growth | -26.24% | 4.86% | -0.14% | 1.42% | 0.59% | -0.08% | 4.57% | 5.56% | 6.46% | 6.68% |
Related:DVA Dividend History·DVA Revenue History·DVA Price History·DVA P/E History·DVA Financial Ratios·DVA Institutional Holders
DVA SEC Filings & Documents
DaVita Inc. (DVA) SEC filings — annual & quarterly reports (10-K, 10-Q)
DVA Frequently Asked Questions
DaVita Inc. (DVA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
DaVita Inc. (DVA) reported $13.84B in revenue for fiscal year 2025. This represents a 4970% increase from $272.9M in 1996.
DaVita Inc. (DVA) grew revenue by 6.5% over the past year. This is steady growth.
Yes, DaVita Inc. (DVA) is profitable, generating $781.4M in net income for fiscal year 2025 (5.5% net margin).
Dividend & Returns
DaVita Inc. (DVA) has a return on equity (ROE) of 46.0%. This is excellent, indicating efficient use of shareholder capital.
DaVita Inc. (DVA) generated $1.49B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.